West Paces Advisors Inc. Bristol Myers Squibb CO Transaction History

West Paces Advisors Inc.

  • $408 Billion
  • Q3 2024

A detailed history of West Paces Advisors Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, West Paces Advisors Inc. holds 434 shares of BMY stock, worth $24,551. This represents 0.01% of its overall portfolio holdings.

Number of Shares
434
Previous 634 31.55%
Holding current value
$24,551
Previous $26.3 Million 14.72%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$39.66 - $51.75 $7,931 - $10,350
-200 Reduced 31.55%
434 $22.5 Million
Q2 2024

Jul 16, 2024
SELL
$40.25 - $52.99 $8,050 - $10,598
-200 Reduced 23.98%
634 $26.3 Million
Q1 2024

Apr 15, 2024
SELL
$47.98 - $54.4 $1,823 - $2,067
-38 Reduced 4.36%
834 $45.2 Million
Q4 2023

Jan 30, 2024
SELL
$48.48 - $57.85 $1,551 - $1,851
-32 Reduced 3.54%
872 $44.7 Million
Q3 2023

Dec 18, 2023
SELL
$57.89 - $64.73 $17,135 - $19,160
-296 Reduced 24.67%
904 $52.5 Million
Q2 2023

Dec 18, 2023
SELL
$63.71 - $70.74 $6,371 - $7,073
-100 Reduced 7.69%
1,200 $76.7 Million
Q1 2023

Dec 18, 2023
BUY
$65.71 - $74.53 $1,445 - $1,639
22 Added 1.72%
1,300 $90.1 Million
Q4 2022

Dec 18, 2023
BUY
$68.48 - $81.09 $87,517 - $103,633
1,278 New
1,278 $92 Million
Q1 2022

Dec 18, 2023
BUY
$61.48 - $73.72 $7,869 - $9,436
128 Added 14.16%
1,032 $75.4 Million
Q4 2021

Dec 19, 2023
BUY
$53.63 - $62.52 $23,168 - $27,008
432 Added 43.11%
1,434 $89.4 Million
Q3 2021

Dec 19, 2023
BUY
$59.17 - $69.31 $16,035 - $18,783
271 Added 37.07%
1,002 $59.3 Million
Q2 2021

Dec 19, 2023
BUY
$61.91 - $67.42 $1,795 - $1,955
29 Added 4.13%
731 $48.8 Million
Q2 2020

Dec 19, 2023
SELL
$54.82 - $64.09 $11,073 - $12,946
-202 Reduced 22.35%
702 $41.3 Million
Q1 2020

Dec 20, 2023
SELL
$46.4 - $67.43 $9,790 - $14,227
-211 Reduced 23.11%
702 $39.1 Million
Q4 2019

Dec 21, 2023
BUY
$49.21 - $64.19 $19,093 - $24,905
388 Added 49.68%
1,169 $75 Million
Q3 2019

Dec 21, 2023
SELL
$42.77 - $50.71 $5,645 - $6,693
-132 Reduced 14.46%
781 $39.6 Million
Q3 2018

Dec 20, 2023
BUY
$55.19 - $62.25 $496 - $560
9 Added 1.0%
913 $56.7 Million
Q1 2018

Dec 21, 2023
SELL
$59.92 - $68.98 $53,928 - $62,082
-900 Reduced 49.64%
913 $57.7 Million
Q4 2017

Dec 21, 2023
SELL
$59.94 - $65.35 $41,958 - $45,744
-700 Reduced 27.86%
1,813 $111 Million
Q1 2017

Dec 21, 2023
BUY
N/A
1,569 Added 166.21%
2,513 $137 Million
Q4 2016

Dec 21, 2023
BUY
N/A
40
944 $55.2 Million

Others Institutions Holding BMY

# of Institutions
2,535
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track West Paces Advisors Inc. Portfolio

Follow West Paces Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email